Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1 (Q27666603)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1	scientific article

Statements

scholarly article

0 references

Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1 (English)

0 references

object named as

human immunodeficiency virus 1

1 reference

based on heuristic

inferred from title

object named as

Jerome Wielens

1

0 references

Martin J. Scanlon

object named as

Martin J Scanlon

8

0 references

David K. Chalmers

object named as

David K Chalmers

7

0 references

Michael W Parker

object named as

Michael W Parker

6

0 references

author name string

Stephen J Headey

2

0 references

John J Deadman

3

0 references

David I Rhodes

4

0 references

Giang T Le

5

0 references

publication date

7 February 2011

0 references

0 references

6

0 references

2

0 references

258-61

0 references

Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Molecular mechanisms of HIV integration and therapeutic intervention

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

HIV resistance to raltegravir

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

A decade of fragment-based drug design: strategic advances and lessons learned

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Discovering high-affinity ligands for proteins: SAR by NMR

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Solution conformation and dynamics of the HIV-1 integrase core domain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Peptide HIV-1 integrase inhibitors from HIV-1 gene products.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivity.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Ligand efficiency: a useful metric for lead selection

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

21 January 2018

Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000483

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.201000483

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27666603&oldid=2162013658"